These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 20579391)

  • 1. Dasatinib reverses cancer-associated fibroblasts (CAFs) from primary lung carcinomas to a phenotype comparable to that of normal fibroblasts.
    Haubeiss S; Schmid JO; Mürdter TE; Sonnenberg M; Friedel G; van der Kuip H; Aulitzky WE
    Mol Cancer; 2010 Jun; 9():168. PubMed ID: 20579391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imatinib mesylate inhibits the proliferation-stimulating effect of human lung cancer-associated stromal fibroblasts on lung cancer cells.
    Kinoshita K; Nakagawa K; Hamada J; Hida Y; Tada M; Kondo S; Moriuchi T
    Int J Oncol; 2010 Oct; 37(4):869-77. PubMed ID: 20811709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Src kinase inhibition induced by dasatinib in non-small cell lung cancer cell lines treated with cisplatin.
    Ceppi P; Papotti M; Monica V; Lo Iacono M; Saviozzi S; Pautasso M; Novello S; Mussino S; Bracco E; Volante M; Scagliotti GV
    Mol Cancer Ther; 2009 Nov; 8(11):3066-74. PubMed ID: 19861409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity of the multikinase inhibitor dasatinib against ovarian cancer cells.
    Konecny GE; Glas R; Dering J; Manivong K; Qi J; Finn RS; Yang GR; Hong KL; Ginther C; Winterhoff B; Gao G; Brugge J; Slamon DJ
    Br J Cancer; 2009 Nov; 101(10):1699-708. PubMed ID: 19861960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-species functional analysis of cancer-associated fibroblasts identifies a critical role for CLCF1 and IL-6 in non-small cell lung cancer in vivo.
    Vicent S; Sayles LC; Vaka D; Khatri P; Gevaert O; Chen R; Zheng Y; Gillespie AK; Clarke N; Xu Y; Shrager J; Hoang CD; Plevritis S; Butte AJ; Sweet-Cordero EA
    Cancer Res; 2012 Nov; 72(22):5744-56. PubMed ID: 22962265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LYN is a mediator of epithelial-mesenchymal transition and a target of dasatinib in breast cancer.
    Choi YL; Bocanegra M; Kwon MJ; Shin YK; Nam SJ; Yang JH; Kao J; Godwin AK; Pollack JR
    Cancer Res; 2010 Mar; 70(6):2296-306. PubMed ID: 20215510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphosignature predicts dasatinib response in non-small cell lung cancer.
    Klammer M; Kaminski M; Zedler A; Oppermann F; Blencke S; Marx S; Müller S; Tebbe A; Godl K; Schaab C
    Mol Cell Proteomics; 2012 Sep; 11(9):651-68. PubMed ID: 22617229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional heterogeneity of cancer-associated fibroblasts from human colon tumors shows specific prognostic gene expression signature.
    Herrera M; Islam AB; Herrera A; Martín P; García V; Silva J; Garcia JM; Salas C; Casal I; de Herreros AG; Bonilla F; Peña C
    Clin Cancer Res; 2013 Nov; 19(21):5914-26. PubMed ID: 24052018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dasatinib, an orally active small molecule inhibitor of both the src and abl kinases, selectively inhibits growth of basal-type/"triple-negative" breast cancer cell lines growing in vitro.
    Finn RS; Dering J; Ginther C; Wilson CA; Glaspy P; Tchekmedyian N; Slamon DJ
    Breast Cancer Res Treat; 2007 Nov; 105(3):319-26. PubMed ID: 17268817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in transcriptional effects of 1α,25 dihydroxyvitamin D3 on fibroblasts associated to breast carcinomas and from paired normal breast tissues.
    Campos LT; Brentani H; Roela RA; Katayama ML; Lima L; Rolim CF; Milani C; Folgueira MA; Brentani MM
    J Steroid Biochem Mol Biol; 2013 Jan; 133():12-24. PubMed ID: 22939885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of dasatinib, a dual SRC/ABL kinase inhibitor, and IPI-504, a heat shock protein 90 inhibitor, against gastrointestinal stromal tumor-associated PDGFRAD842V mutation.
    Dewaele B; Wasag B; Cools J; Sciot R; Prenen H; Vandenberghe P; Wozniak A; Schöffski P; Marynen P; Debiec-Rychter M
    Clin Cancer Res; 2008 Sep; 14(18):5749-58. PubMed ID: 18794084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression profile of normal and cancer-associated fibroblasts according to intratumoral inflammatory cells phenotype from breast cancer tissue.
    González L; Eiro N; Fernandez-Garcia B; González LO; Dominguez F; Vizoso FJ
    Mol Carcinog; 2016 Nov; 55(11):1489-1502. PubMed ID: 26349857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin suppresses the proliferation and tumorigenicity of Cal27 by modulating cancer-associated fibroblasts of TSCC.
    Ba P; Xu M; Yu M; Li L; Duan X; Lv S; Fu G; Yang J; Yang P; Yang C; Sun Q
    Oral Dis; 2020 Oct; 26(7):1375-1383. PubMed ID: 32060973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and functional signature of genes regulated by structurally different ABL kinase inhibitors.
    Nunoda K; Tauchi T; Takaku T; Okabe S; Akahane D; Sashida G; Ohyashiki JH; Ohyashiki K
    Oncogene; 2007 Jun; 26(28):4179-88. PubMed ID: 17213809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical evaluation of dasatinib, a potent Src kinase inhibitor, in melanoma cell lines.
    Eustace AJ; Crown J; Clynes M; O'Donovan N
    J Transl Med; 2008 Sep; 6():53. PubMed ID: 18823558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dasatinib inhibits migration and invasion in diverse human sarcoma cell lines and induces apoptosis in bone sarcoma cells dependent on SRC kinase for survival.
    Shor AC; Keschman EA; Lee FY; Muro-Cacho C; Letson GD; Trent JC; Pledger WJ; Jove R
    Cancer Res; 2007 Mar; 67(6):2800-8. PubMed ID: 17363602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dasatinib (BMS-354825) selectively induces apoptosis in lung cancer cells dependent on epidermal growth factor receptor signaling for survival.
    Song L; Morris M; Bagui T; Lee FY; Jove R; Haura EB
    Cancer Res; 2006 Jun; 66(11):5542-8. PubMed ID: 16740687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ionizing Radiation Curtails Immunosuppressive Effects From Cancer-Associated Fibroblasts on Dendritic Cells.
    Berzaghi R; Tornaas S; Lode K; Hellevik T; Martinez-Zubiaurre I
    Front Immunol; 2021; 12():662594. PubMed ID: 34177901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinome profiling of chondrosarcoma reveals SRC-pathway activity and dasatinib as option for treatment.
    Schrage YM; Briaire-de Bruijn IH; de Miranda NF; van Oosterwijk J; Taminiau AH; van Wezel T; Hogendoorn PC; Bovée JV
    Cancer Res; 2009 Aug; 69(15):6216-22. PubMed ID: 19602594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor β signaling overcomes dasatinib resistance in lung cancer.
    Gordian E; Li J; Pevzner Y; Mediavilla-Varela M; Luddy K; Ohaegbulam K; Daniel KG; Haura EB; Muñoz-Antonia T
    PLoS One; 2014; 9(12):e114131. PubMed ID: 25501935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.